Skip to content
★ Sign in to follow
II

Inventera Inc. Stock: price and insider trades · South Korea

인벤테라

KR·Mcap ₩67BHealth Care

No insider purchase over the last 90 days. The latest, by 신태현, was filed 09 Apr 2026.

Inventera Inc.: what insiders have been doing

Inventera Inc. belongs to the Health Care sector. Filings by its managers are published through DART (FSS). In the past year (3 November 2025 to 3 November 2026), 9 filings came from 8 insiders.

Only purchases show up on the open market, 9 purchases in all, filed by 8 insiders. The amount is not disclosed for 9 filings. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Among those who bought: 2 chief executives and 1 board member.

The last insider purchase was made public on 9 April 2026, 215 days ago. Typically, a trade is published a median of 7 days after it takes place. That lag is the time during which only the insider knows about the trade.

Compared with its exchange (2,655 companies, median 7 filings), a count of 9 filings is above the norm. Looking back to 2026, when coverage begins, insiders filed 9 purchases and no sales.

Elsewhere in the same sector, our signals recently picked up insider purchases at Dynavox Group AB and UCB. These figures are compiled from regulatory filings published by DART (FSS). They describe what insiders did and are not a recommendation.

Insider Decl.
9
Thresholds
n/a
Buy Volume
€26M
9 ops. · all time
Sell Volume
n/a
n/a

Who traded when

BuySale
신태현2 buys
공은아1 buy
김지욱1 buy
라이트팜텍1 buy
메디톡스벤처투자1 buy
우리벤처파트너스1 buy

+2 other insiders

Since the insiders bought

  • Filed 09 Apr 2026 · 215 days ago
    -69.0%
    Entry ₩25,250 · Close 02 Nov 2026 ₩7,840
  • Filed 09 Apr 2026 · 215 days ago · €7.3M
    -69.0%
    Entry ₩25,250 · Close 02 Nov 2026 ₩7,840
  • Filed 09 Apr 2026 · 215 days ago
    -69.0%
    Entry ₩25,250 · Close 02 Nov 2026 ₩7,840

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Financial data

· cache

₩8,520
Analyst consensus
·
Profitability & ownership
% insiders39.9%
% institutions9.1%
Last declaration on 9 April 2026
Declarations11 total
  • Other
    Other(filed)
    0DART
  • Other
    Other(filed)
    0DART
  • ▲
    Executives
    0DART
    3,449,478 sharesKRXDART:20260409002316
    Canonical exit: 1 Jul 2026 (T+90)
  • ▲
    Executives
    €7.3Mest.0DART
    465,212 sharesKRXDART:20260409001070
    Canonical exit: 1 Jul 2026 (T+90)
  • ▲
    대표이사Executives
    0DART
    1,442,782 sharesShareKRXDART:20260409002402
    Canonical exit: 1 Jul 2026 (T+90)
  • ▲
    -Executives
    0DART
    871,904 sharesShareKRXDART:20260409002505
    Canonical exit: 1 Jul 2026 (T+90)
  • ▲
    상무이사Executives
    €459kest.0DART
    21,032 sharesShareKRXDART:20260409002479
    Canonical exit: 1 Jul 2026 (T+90)
  • ▲
    사장Executives
    €918kest.0DART
    42,086 sharesShareKRXDART:20260409002454
    Canonical exit: 1 Jul 2026 (T+90)
  • ▲
    Related company / holdingExecutives
    €6.1Mest.0DART
    396,654 sharesKRXDART:20260408002685
    Canonical exit: 1 Jul 2026 (T+90)
  • ▲
    €6.2Mest.0DART
    368,412 sharesKRXDART:20260407003267
    Canonical exit: 1 Jul 2026 (T+90)
  • ▲
    Executives
    €4.8Mest.0DART
    286,579 sharesKRXDART:20260407001552
    Canonical exit: 1 Jul 2026 (T+90)

11 of 11 declarations

About Inventera Inc.

Inventaera is a healthcare and pharmaceutical company listed on the XKRX. It focuses on developing innovative solutions to enhance healthcare.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations